Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 4–4 | Cite as

Zinbryta withdrawals following inflammatory brain disorders

News item

References

  1. 1.
    Therapeutic Goods Administration. Zinbryta (daclizumab). Internet Document : 15 Mar 2018. Available from: URL: https://www.tga.gov.au/alert/zinbryta-daclizumab.
  2. 2.
    Government of Canada. ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis. Internet Document : 16 Mar 2018. Available from: URL: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66214a-eng.php.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations